vs
Side-by-side financial comparison of Healthcare Triangle, Inc. (HCTI) and Peraso Inc. (PRSO). Click either name above to swap in a different company.
Healthcare Triangle, Inc. is the larger business by last-quarter revenue ($3.1M vs $2.9M, roughly 1.1× Peraso Inc.). Peraso Inc. runs the higher net margin — -43.3% vs -143.4%, a 100.1% gap on every dollar of revenue. On growth, Healthcare Triangle, Inc. posted the faster year-over-year revenue change (43.4% vs -22.0%). Over the past eight quarters, Peraso Inc.'s revenue compounded faster (1.0% CAGR vs -12.6%).
Healthcare Triangle, Inc. is a healthcare technology firm that delivers cloud-native data management platforms, AI-powered clinical analytics, and digital workflow solutions. It serves U.S. healthcare providers, payers, and life science organizations, supporting clinical decision-making, care coordination, and operational efficiency across the care continuum.
Peraso Inc. is a semiconductor technology firm specializing in the design and production of high-performance millimeter wave (mmWave) integrated circuits and modules. It delivers 5G and next-generation wireless connectivity solutions for telecom infrastructure, industrial IoT, fixed wireless access and consumer electronics segments, serving customers across North America, Asia Pacific and European markets.
HCTI vs PRSO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.1M | $2.9M |
| Net Profit | $-4.5M | $-1.2M |
| Gross Margin | — | 52.2% |
| Operating Margin | -141.4% | -44.6% |
| Net Margin | -143.4% | -43.3% |
| Revenue YoY | 43.4% | -22.0% |
| Net Profit YoY | -234.0% | 20.3% |
| EPS (diluted) | $-151.13 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.1M | $2.9M | ||
| Q3 25 | $3.5M | $3.2M | ||
| Q2 25 | $3.6M | $2.2M | ||
| Q1 25 | $3.7M | $3.9M | ||
| Q4 24 | $2.2M | $3.7M | ||
| Q3 24 | $2.4M | $3.8M | ||
| Q2 24 | $3.0M | $4.2M | ||
| Q1 24 | $4.1M | $2.8M |
| Q4 25 | $-4.5M | $-1.2M | ||
| Q3 25 | $-1.9M | $-1.2M | ||
| Q2 25 | $-1.4M | $-1.8M | ||
| Q1 25 | $-1.7M | $-471.0K | ||
| Q4 24 | $-1.3M | $-1.6M | ||
| Q3 24 | $-1.2M | $-2.7M | ||
| Q2 24 | $-1.5M | $-4.4M | ||
| Q1 24 | $-1.9M | $-2.0M |
| Q4 25 | — | 52.2% | ||
| Q3 25 | — | 56.2% | ||
| Q2 25 | — | 48.3% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | 55.5% | ||
| Q1 24 | — | 46.4% |
| Q4 25 | -141.4% | -44.6% | ||
| Q3 25 | -74.3% | -36.8% | ||
| Q2 25 | -38.2% | -80.0% | ||
| Q1 25 | -37.7% | -13.3% | ||
| Q4 24 | -22.5% | -44.3% | ||
| Q3 24 | -48.4% | -70.3% | ||
| Q2 24 | -46.2% | -105.6% | ||
| Q1 24 | -41.7% | -128.9% |
| Q4 25 | -143.4% | -43.3% | ||
| Q3 25 | -54.6% | -37.4% | ||
| Q2 25 | -38.4% | -82.4% | ||
| Q1 25 | -45.9% | -12.2% | ||
| Q4 24 | -61.6% | -42.4% | ||
| Q3 24 | -51.8% | -70.6% | ||
| Q2 24 | -50.6% | -104.4% | ||
| Q1 24 | -45.3% | -72.1% |
| Q4 25 | $-151.13 | $-0.09 | ||
| Q3 25 | $-0.42 | $-0.17 | ||
| Q2 25 | $-0.58 | $-0.31 | ||
| Q1 25 | $-0.17 | $-0.10 | ||
| Q4 24 | $-16783.38 | $0.36 | ||
| Q3 24 | $-54.78 | $-0.98 | ||
| Q2 24 | $-70.72 | $-1.88 | ||
| Q1 24 | $-0.42 | $-1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.6M | $2.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.9M | $4.6M |
| Total Assets | $22.7M | $6.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.6M | $2.9M | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $6.8M | — | ||
| Q4 24 | $20.0K | $3.3M | ||
| Q3 24 | $28.0K | $1.3M | ||
| Q2 24 | $29.0K | $1.9M | ||
| Q1 24 | $301.0K | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $888.0K | — |
| Q4 25 | $9.9M | $4.6M | ||
| Q3 25 | $8.7M | $3.6M | ||
| Q2 25 | $10.2M | $3.0M | ||
| Q1 25 | $8.6M | $3.6M | ||
| Q4 24 | $-5.1M | $3.5M | ||
| Q3 24 | $-1.8M | $2.0M | ||
| Q2 24 | $-646.0K | $3.6M | ||
| Q1 24 | $-511.0K | $6.7M |
| Q4 25 | $22.7M | $6.1M | ||
| Q3 25 | $13.8M | $6.2M | ||
| Q2 25 | $14.6M | $5.5M | ||
| Q1 25 | $11.8M | $6.7M | ||
| Q4 24 | $2.0M | $7.2M | ||
| Q3 24 | $4.8M | $7.2M | ||
| Q2 24 | $6.0M | $9.8M | ||
| Q1 24 | $6.9M | $11.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.8M | $-1.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.8M | $-1.1M | ||
| Q3 25 | $-1.5M | $-1.5M | ||
| Q2 25 | $-2.6M | $-2.0M | ||
| Q1 25 | $-5.6M | $-966.0K | ||
| Q4 24 | $-811.0K | $-687.0K | ||
| Q3 24 | $715.0K | $-683.0K | ||
| Q2 24 | $-935.0K | $-659.0K | ||
| Q1 24 | $-50.0K | $-2.5M |
| Q4 25 | — | — | ||
| Q3 25 | $-1.5M | $-1.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -43.0% | -48.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCTI
| Software Services | $2.4M | 78% |
| Managed Services And Support | $609.0K | 19% |
| Other | $88.0K | 3% |
PRSO
| Products | $2.8M | 96% |
| Other | $105.0K | 4% |
